Product details
GLP1-S-30 is an upstream reference code in which the 'S' designates Semaglutide-class material (the selective GLP-1 mono-agonist branch, distinct from the 'T' Tirzepatide-class and 'R' Retatrutide-class codes) and '30mg' the fill quantity. The letter convention is supplier-internal and not standardized across the industry, so the code is not a reliable identity statement on its own — the API identity, sequence, and salt form are confirmed against the released batch-specific COA at order time. For direct procurement the named Semaglutide reference standard is the cleaner route because all documentation attaches to an unambiguous molecule.
On a confirmed Semaglutide-class lot the analytical packet is the standard reference-grade set: RP-HPLC purity (gradient method, UV 214 nm), ESI-MS identity (Semaglutide confirms at ≈4113 Da), LC-MS/MS sequence verification on request, counter-ion content, and water content by Karl Fischer. Confirm API by COA / label before use. This is reference-grade research material, distinct from compounding-scale API supply.
Regulatory note: Supplier reference code, not a chemical identity. Confirm API identity by batch-specific COA / label before order placement. Sold for Research Use Only under the receiving laboratory's institutional and jurisdictional regulations — not a finished dosage form and not labelled for human administration.
FAQ
- Why does the 'S' code typically map to Semaglutide-class material?
- Upstream metabolic-GLP-1 naming conventions use single-letter codes for the API class within the family — 'S' for Semaglutide-class mono-agonist, 'T' for Tirzepatide-class dual agonist, 'R' for Retatrutide-class tri-agonist. The convention is supplier-internal and not industry-standardized, so the customer-facing COA always confirms the specific API regardless of the catalog code; buyers should not rely on the letter alone.
- Could an 'S' code ever resolve to a different GLP-1 mono-agonist?
- It is uncommon but the only definitive disambiguation is the COA. The ESI-MS check resolves the question at the batch level — Semaglutide confirms at ≈4113 Da, and a different mono-agonist would land at a different mass. Buyers concerned about the distinction should request explicit clarification at quote stage before order placement.
- Is bulk Semaglutide reference material the same molecule regardless of finished-product route?
- At the molecular level, yes — subcutaneous and oral finished formulations share the same API; the differences live in the finished-product formulation, not the bulk active. The reference-standard analytical packet confirms identity at the molecular level (RP-HPLC purity, ESI-MS at ≈4113 Da, counter-ion, water content), which is the relevant question for a reference standard.
Certificate of Analysis (COA)
The per-lot COA for this product will appear here.